Innovative Diagnostics, Empowered by Intelligence | Hotgen's Successful Debut at MEDICA 2024

From November 11 to 14, 2024, the international medical device exhibition MEDICA 2024 was successfully held in Düsseldorf, Germany. Beijing Hotgen Biotechnology Co., Ltd. set up two booths at the event, located at Hall 3 (3 96-4) and Hall 1 (1 A 07), attracting visitors and industry experts from around the world.

During the exhibition, Hotgen showcased a range of highly recognized innovative products, including the compact and intelligent MQ60 series single-use chemiluminescence system, the UPT ultra-sensitive luminescent immunoassay solution, as well as highly accurate small molecule sandwich diagnostic reagents and IVD reagent raw materials. These products demonstrated the company's leading technologies and R&D capabilities in the field of in vitro diagnostics, earning high praise and attention from visitors.

Adhering to its mission of "Advancing Biotechnology for the Benefit of Human Health," Hotgen continues to drive innovation and development in in vitro diagnostic technology. This exhibition further deepened global partners' understanding of the company's products and technologies, laying a solid foundation for future collaboration.

Hotgen sincerely thanks every visitor for their attention and support and looks forward to more international opportunities in the future, working together with global partners to continuously advance medical diagnostic technologies.